Skip to main content

BMT APTALIS Pill - white capsule/oblong, 22mm

Generic Name: bismuth subcitrate potassium/metronidazole/tetracycline

Pill with imprint BMT APTALIS is White, Capsule/Oblong and has been identified as Pylera bismuth subcitrate potassium 140 mg / metronidazole 125 mg / tetracycline hydrochloride 125 mg. It is supplied by Allergan, Inc.

Pylera is used in the treatment of Helicobacter Pylori Infection and belongs to the drug class H. pylori eradication agents. There is positive evidence of human fetal risk during pregnancy. Pylera bismuth subcitrate potassium 140 mg / metronidazole 125 mg / tetracycline hydrochloride 125 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for BMT APTALIS

Pylera bismuth subcitrate potassium 140 mg / metronidazole 125 mg / tetracycline hydrochloride 125 mg BMT APTALIS
Pylera bismuth subcitrate potassium 140 mg / metronidazole 125 mg / tetracycline hydrochloride 125 mg BMT APTALIS
Pylera bismuth subcitrate potassium 140 mg / metronidazole 125 mg / tetracycline hydrochloride 125 mg BMT APTALIS

Pylera

Generic Name
bismuth subcitrate potassium/metronidazole/tetracycline
Imprint
BMT APTALIS
Strength
bismuth subcitrate potassium 140 mg / metronidazole 125 mg / tetracycline hydrochloride 125 mg
Color
White
Size
22.00 mm
Shape
Capsule/Oblong
Availability
Prescription only
Drug Class
H. pylori eradication agents
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Allergan, Inc.
National Drug Code (NDC)
58914-0601
Inactive Ingredients
magnesium stearate, magnesium silicate, lactose monohydrate, gelatin, titanium dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related images for "BMT APTALIS"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.